MedX Health (CVE:MDX) Sets New 1-Year High at $0.09

MedX Health Corp (CVE:MDXGet Free Report) shares hit a new 52-week high during mid-day trading on Friday . The company traded as high as C$0.09 and last traded at C$0.09, with a volume of 320751 shares. The stock had previously closed at C$0.08.

MedX Health Trading Up 6.3 %

The business has a fifty day moving average of C$0.06 and a 200-day moving average of C$0.06. The firm has a market cap of C$22.27 million, a PE ratio of -2.67 and a beta of 1.21.

MedX Health (CVE:MDXGet Free Report) last issued its quarterly earnings data on Wednesday, March 6th. The company reported C($0.53) earnings per share (EPS) for the quarter. The company had revenue of C$26.41 million during the quarter. On average, equities analysts forecast that MedX Health Corp will post 0.0029191 EPS for the current year.

MedX Health Company Profile

(Get Free Report)

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.

Further Reading

Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.